Hemodynamic Monitoring Systems Market Drivers and Key Players Strategies Analyzed

“The hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4% during the forecast period.”
The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. Technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, and government focus on critical care infrastructure & services are expected to drive the growth of the hemodynamic monitoring systems market. However, the risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market to a certain extent.

“By product, the monitors segment is expected to grow at the highest rate during the forecast period.”
Based on product, the global hemodynamic monitoring systems market is segmented into two broad categories—monitors and disposables. The monitors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing prevalence of CVDs; technological advancements in monitoring systems; increasing funding by government authorities for improving patient-centered care, safety, and efficiency; and the ability of hemodynamic monitors to improve cath lab efficiency.

Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-110152

“By type, the noninvasive systems segment is expected to grow at the highest rate during the forecast period (2018–2023).”
On the basis of type, the hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive systems. The noninvasive hemodynamic monitoring systems segment is expected to grow at the highest CAGR during the forecast owing to the benefits it offers such as reduced staffing costs, treatment expenses, and hospital stay. Furthermore, the rising incidence of respiratory disorders; fewer complications of noninvasive hemodynamic monitoring compared to invasive methods, enhanced portability & precision, and ease of use are additional factors driving the growth of this market segment.

“By end user, the clinics and ambulatory care centers segment is expected to grow at the highest rate during the forecast period.”
On the basis of end user, the global hemodynamic monitoring systems market is segmented into hospitals, clinics and ambulatory care centers (ACCs), and home care settings. The clinics and ACCs segment is expected to register the highest CAGR during the forecast period due to the growing number of ambulatory care centers globally, improving reimbursements for ACCs, growing number of patients visiting clinics & ACCs, and increasing number of initiatives by governments.

Christophe Rude
Christophe Rude
Articles: 15880